Albert David Share Price

Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the Kothari Group. The Companys principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers.ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto the world leader in amino acids to manufacture amino acid infusions, for which it came out with a rights issue in Aug.87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.90 augmented the longterm working capital. ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.During 199899, the company has developed some new products viz. Siozole Capsules and FerrochelateZCapsules with Iron Zinc and folic acid in sustained released formulation. In 200203 the company has launched new productsINTECAR,NIMERILT,EVICT,ALROF50. It is also planning to launch new products such as SIOOXY,ALAMIN FEZ,PANSURE.New products were launched such as INTECAR Capsules, NIMERILT, EVICT, ALROF50, ADLIN and SLOZIN during the year 2003 new products such as AlaminFeZ and Pansure were introduced in 2004. SIOOXY (AntiOxidant with OMEGA3 Fatty Acid) was launched in 2005, launched ALAMTNXtra, VERBET the antivertigo drug and water for injection during year 2006 launched Antibiotic Azithromycin under brand AZ3 and expanded its Vision Care range (launched Antiglaucoma products, Antiinfectives, Irrigating Solution and Steroidal combinations) in 2009 launched uterine tonicSiocare and Laxative combinationEvict Fibre and has also expanded its Antiinflammatory Analgesic range with launch of Anaflam XP in 2010 launched Rabeprazole and its combination (AntiPeptic Ulcerant range) and Montelukast and its combination (Anti Asthmatic range) in 2013 launched Alamin Liquid and Alamin RLD (LArginine Sachet) in 2014 launched Dhup Tab Drop (Vit.D3), InbalanseZ (probiotic) and EvictXF (Laxative) in 2015 launched Sioneuron M/PG capsules, InbalanseZ capsules and BreazeFx tablet in 2017. It introduced two products i.e., Evacure and C3H in the market during year 202122.

As of 7 Mar 2026, Albert David share price is ₹680. The stock opened at ₹680.8 and had closed at ₹681.6 the previous day. During today’s trading session, Albert David share price moved between ₹673.55 and ₹687.00, with an average price for the day of ₹680.27. Over the last 52 weeks, the stock has recorded a low of ₹663.35 and a high of ₹957.50. In terms of performance, Albert David share price has declined by 15.1% over the past six months and has declined by 21.78% over the last year.